International Clinical Trial: Perioperative Intravenous Lidocaine Infusion Reduces the Risk of Postoperative Recurrence and Metastasis of Pancreatic Cancer: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127030) titled 'Perioperative Intravenous Lidocaine Infusion Reduces the Risk of Postoperative Recurrence and Metastasis of Pancreatic Cancer: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial' on June 23.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

Condition: Pancreatic cancer

Intervention: Trial group:Lidocaine intravenous infusion: Intravenous injection of 1.5 mg/kg based on ideal body weight (IBW) during anesthesia induction, completed within 10 minutes, followed by continuous infusion at 1.5 mg/kg/h intraoper...